WALGREENS BOOTS ALLIANCE INC (WBA) Stock Price & Overview

NASDAQ:WBAUS9314271084

Current stock price

11.98 USD
+0.06 (+0.5%)
At close:
12.04 USD
+0.06 (+0.5%)
After Hours:

The current stock price of WBA is 11.98 USD. Today WBA is up by 0.5%. In the past month the price increased by 3.01%. In the past year, price increased by 29.51%.

WBA Key Statistics

52-Week Range8.08 - 13.2495
Current WBA stock price positioned within its 52-week range.
1-Month Range11.59 - 12.25
Current WBA stock price positioned within its 1-month range.
Market Cap
10.369B
P/E
6.27
Fwd P/E
7.67
EPS (TTM)
1.91
Dividend Yield
N/A

WBA Stock Performance

Today
+0.5%
1 Week
-1.80%
1 Month
+3.01%
3 Months
+6.49%
Longer-term
6 Months +12.17%
1 Year +29.51%
2 Years -52.67%
3 Years -65.83%
5 Years -68.49%
10 Years -86.16%

WBA Stock Chart

WALGREENS BOOTS ALLIANCE INC / WBA Daily stock chart

WBA Technical Analysis

ChartMill assigns a technical rating of 10 / 10 to WBA. When comparing the yearly performance of all stocks, WBA is one of the better performing stocks in the market, outperforming 76.31% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

WBA Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to WBA. Both the profitability and financial health of WBA have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

WBA Earnings

On June 26, 2025 WBA reported an EPS of 0.38 and a revenue of 38.99B. The company beat EPS expectations (10.66% surprise) and beat revenue expectations (4.78% surprise).

Next Earnings DateOct 13, 2025
Last Earnings DateJun 26, 2025
PeriodQ3 / 2025
EPS Reported$0.38
Revenue Reported38.986B
EPS Surprise 10.66%
Revenue Surprise 4.78%

WBA Forecast & Estimates

11 analysts have analysed WBA and the average price target is 10.81 USD. This implies a price decrease of -9.75% is expected in the next year compared to the current price of 11.98.

For the next year, analysts expect an EPS growth of -38.04% and a revenue growth 6.29% for WBA


Analysts
Analysts49.09
Price Target10.81 (-9.77%)
EPS Next Y-38.04%
Revenue Next Year6.29%

WBA Groups

Sector & Classification

WBA Financial Highlights

Over the last trailing twelve months WBA reported a non-GAAP Earnings per Share(EPS) of 1.91. The EPS decreased by -39.56% compared to the year before.


Income Statements
Revenue(TTM)154.58B
Net Income(TTM)-6.30B
Industry RankSector Rank
PM (TTM) N/A
ROA -9.07%
ROE -87.68%
Debt/Equity 1.09
Chartmill High Growth Momentum
EPS Q2Q%-39.68%
Sales Q2Q%7.25%
EPS 1Y (TTM)-39.56%
Revenue 1Y (TTM)6.22%

WBA Ownership

Ownership
Inst Owners61.25%
Shares865.56M
Float857.99M
Ins Owners0.64%
Short Float %N/A
Short RatioN/A

About WBA

Company Profile

WBA logo image Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. The company is headquartered in Deerfield, Illinois and currently employs 193,000 full-time employees. The company went IPO on 2014-12-31. The Company’s segments include U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment includes the Walgreens business, which includes the operations of retail drug stores, health and wellness services, and specialty and home delivery pharmacy services, and its equity method investment in Cencora, Inc. The International segment consists of pharmacy-led health and beauty retail businesses outside the United States and a pharmaceutical wholesaling and distribution business in Germany. The pharmacy-led health and beauty retail businesses include Boots branded stores in the United Kingdom, the Republic of Ireland and Thailand, and the Benavides brand in Mexico. The firm's U.S. Healthcare segment is a consumer-centric, technology-enabled healthcare business that engages consumers through a personalized, omni-channel experience across the care journey.

Company Info

IPO: 2014-12-31

WALGREENS BOOTS ALLIANCE INC

108 Wilmot Rd

Deerfield ILLINOIS 60015 US

CEO: Rosalind Brewer

Employees: 252500

WBA Company Website

WBA Investor Relations

Phone: 18473152500

WALGREENS BOOTS ALLIANCE INC / WBA FAQ

What does WALGREENS BOOTS ALLIANCE INC do?

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. The company is headquartered in Deerfield, Illinois and currently employs 193,000 full-time employees. The company went IPO on 2014-12-31. The Company’s segments include U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment includes the Walgreens business, which includes the operations of retail drug stores, health and wellness services, and specialty and home delivery pharmacy services, and its equity method investment in Cencora, Inc. The International segment consists of pharmacy-led health and beauty retail businesses outside the United States and a pharmaceutical wholesaling and distribution business in Germany. The pharmacy-led health and beauty retail businesses include Boots branded stores in the United Kingdom, the Republic of Ireland and Thailand, and the Benavides brand in Mexico. The firm's U.S. Healthcare segment is a consumer-centric, technology-enabled healthcare business that engages consumers through a personalized, omni-channel experience across the care journey.


What is the stock price of WALGREENS BOOTS ALLIANCE INC today?

The current stock price of WBA is 11.98 USD. The price increased by 0.5% in the last trading session.


What is the dividend status of WALGREENS BOOTS ALLIANCE INC?

WBA does not pay a dividend.


What is the ChartMill technical and fundamental rating of WBA stock?

WBA has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


How is the valuation of WALGREENS BOOTS ALLIANCE INC (WBA) based on its PE ratio?

The PE ratio for WALGREENS BOOTS ALLIANCE INC (WBA) is 6.27. This is based on the reported non-GAAP earnings per share of 1.91 and the current share price of 11.98 USD.


Can you provide the ownership details for WBA stock?

You can find the ownership structure of WALGREENS BOOTS ALLIANCE INC (WBA) on the Ownership tab.